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Abstract 
Subcutaneous adipose tissue was defined as the “perfect filler” as is soft and malleable and is usually enough 
present in the body for correcting volume defects and small remodelling purposes. The first attempts to implant 
autologous adipose tissue dates back to the end of the twentieth century, and with the refinement of harvesting, 
processing and replanting techniques today a uniform and predictable amount of survival rate were achieved. 
Those improvements have led to wider use of autologous fat grafts in many medical specialities not only in 
aesthetic or reconstructive treatments. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Subcutaneous adipose tissue was defined as 
the “perfect filler” as is soft and malleable and is 
usually enough present in the body for correcting 
volume defects and small remodelling purposes. The 
first attempts to implant autologous adipose tissue 
dates back to the end of the twentieth century [1] and 
after those initial attempts was proposed by many 
authors to correct many defects with variable results 
but the real change in application of fat transplantation 
was possible after the publication of Coleman's 
studies [2], [3], [4]. Coleman modified and corrected 
the methods of his predecessors and proposed a 
protocol for the treatment of adipose tissue that 
insured standardised results. According to Coleman’s 
studies, the key to successful fat grafting lies in 
harvesting, refinement, and transfer technique to 
provide pure, intact parcels of fat, essential for 
successful grafting. Also, those refined fat parcels 
must be infiltrated into the recipient site in very small 
amounts to be integrated into the host tissues and to 
survive predictably and uniformly. Having achieved a 
good survival rate of transplanted fat, many Authors 
started to use it to treat many different conditions. 
 
The biology of transplanted fat survival 
Colemand and other Authors focused on the 
main problem after adipose tissue auto-
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transplantation, namely its absorption rate over time 
(reported reduction varies from 25 to 70% of the total 
implanted volume) [4], [5], [6]. The “Cellular survival 
theory” introduced by Peer argues that the final 
volume that can be obtained after an adipose tissue 
transplant depends on the number of vital adipocytes 
present at the time of transplantation [5], but further 
studies have shown that mature adipocytes are very 
fragile cells and have a low level of resistance to 
trauma and ischemia. In autologous fat graft there are 
other cellular populations more resistant to hypoxia 
and traumatic insults caused by the procedures for 
harvesting, processing and replanting: the 
preadipocytes or adipose-derived stromal cells 
(ASCs), this is because all immature progenitor cells 
have a minimal metabolic activity and thus are able to 
survive much longer without having all metabolic 
requirements fulfilled [7], [8]. 
Recent Authors identify three zones in fat 
grafting: a thin outer zone with the best chances of 
survival, an intermediate zone where regeneration 
takes place and a central zone doomed to necrosis. 
According to Eto et al., the biggest volume of a fat 
graft retained depends on the degree of survival in 
regenerating zone, which contains ASCs with the 
potential for differentiation and replacement of 
adipocytes lost in the necrotic zone [9], [10].  
In addition to contributing to adipogenesis 
within transplanted adipose tissue, ASCs have an 
important role in graft revascularisation via paracrine 
effects that act in combination with another cellular 
population the Stromal Vascular Fraction (SVF). Both 
ASCs and SVF have a role in long-term survival of the 
transplanted fat tissue because exerting paracrine 
secretion of several factors such as VEGF, HGF and 
TGF-β, which are released due to many stimuli, 
including hypoxia and inflammation, and those stimuli 
strongly affect the differentiation of stem cells and 
induce angiogenesis causing an overall remodelling of 
host tissue. Also, thanks to the angiogenic factors 
released from ASCs and SVF, lipofilling helps to 
interrupt the vicious circle of vascular lesion caused 
by ischaemia, hyperpermeability, and fibrosis leading 
to more ischaemia, helping the growth of a 
microvascular bed with the correct ratio of adipocytes 
to capillaries [10], [11], [12].  
 
Recent applications of autologous fat 
 grafts 
Many studies demonstrated the capacity, 
provided by their unique cytokine and growth factor 
profiles of ASCs to undergo multilineage 
differentiation, not just into fat but also into bone, 
cartilage, skeletal muscle, cardiac muscle, blood 
vessels, nerves and skin [13], [14]. For this reason 
recent studies have shown the utility of transplanted 
ASCs contained in lipoaspirate as an highly effective 
therapeutic approach to treat many different kinds of 
conditions including degenerative, chronic lesions, 
late effects of oncologic radiation treatments, 
scleroderma and burns in addition to the well-known 
role in the treatment of lipodystrophy of face and 
body, recontouring and rejuvenation of the aging face 
and hands or treatment of depressed or altered 
scars[15], [16], [17], [18], [19], [20].  
There are also many works supporting the 
efficacy of fat grafting in surgical applications like in 
temporomandibular joint surgery, for treatment and 
prevention of ankylosis, fibrosis or heterotopic 
ossification in total joint prosthesis; in neurosurgery to 
treat or prevent cerebrospinal fluid leaks in spine and 
skull base surgeries; in otolaryngology for obliteration 
of ear, frontal sinus cavities, vocal cord surgery and 
cleft lip and palate reconstruction and in breast 
oncology as a vehicle for antiestrogens [21], [23], [24]. 
Since from early Coleman’s observations, an 
improvement of pigmentation has also been recorded 
therefore in the latest proposals for the application of 
autologous fat grafting is used in vitiligo and grey hair 
in combination with other treatments. Initial attempts 
to use ASCs to treat alopecia with good results were 
also made [25], [26], [27]. 
In conclusion, fat is the closest to the ideal 
filler because it is readily available; easily obtainable, 
with low donor-site morbidity; repeatable; inexpensive; 
versatile, and biocompatible. Also, its use can help to 
treat a wide variety of condition aside from 
reconstructive and cosmetic procedures making it an 
invaluable tool in regenerative medicine and surgery. 
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